Liposuction for Lipedema Significantly Reduces Benzodiazepine Dependence: A Prospective Cohort Study

Area of Science:

• Plastic Surgery
• Psychiatry
• Endocrinology

Background:

• Lipedema is a chronic adipose disorder causing pain, limited mobility, and psychological distress.
• Patients with lipedema are often prescribed benzodiazepines (BNZ) for associated anxiety or depressive symptoms.
• Previous studies suggest body contouring may reduce BNZ use in patients with anxiety disorders.

Purpose of the Study:

• To investigate the effect of liposuction on benzodiazepine (BNZ) use in women with lipedema.
• To assess the impact of liposuction on anxiety, pain, sleep quality, and body image in this patient population.

Main Methods:

• Retrospective observational study of 100 adult female patients with Stage I-III lipedema.
• Participants underwent tumescent or water-assisted liposuction and were on stable BNZ therapy for at least six months pre-surgery.
• Primary outcome: BNZ usage at six months postoperatively. Secondary outcomes: anxiety, pain, sleep quality, and body image assessed pre- and post-surgery.

Main Results:

• At six months post-surgery, 77% of patients reduced or discontinued BNZ (32% stopped entirely).
• Average daily BNZ dosage decreased significantly (p < 0.001).
• Statistically significant improvements observed in anxiety, pain, sleep quality, and body image (all p < 0.001), correlating with reduced BNZ use.

Conclusions:

• Liposuction for lipedema improves physical symptoms and supports psychological recovery, reducing benzodiazepine dependence.
• Surgical treatment can be a valuable component of an integrated approach for managing lipedema's somatic and mental health aspects.
• Further research is warranted to confirm long-term effects and elucidate underlying mechanisms.